CN116634890A - Bioconversion process development and application of functional black bean flour by biotransformation of enzyme group derived from bacillus - Google Patents
Bioconversion process development and application of functional black bean flour by biotransformation of enzyme group derived from bacillus Download PDFInfo
- Publication number
- CN116634890A CN116634890A CN202180077992.6A CN202180077992A CN116634890A CN 116634890 A CN116634890 A CN 116634890A CN 202180077992 A CN202180077992 A CN 202180077992A CN 116634890 A CN116634890 A CN 116634890A
- Authority
- CN
- China
- Prior art keywords
- bioconversion
- strain
- bacillus polyfermenticus
- kctc
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000004190 Enzymes Human genes 0.000 title abstract description 36
- 108090000790 Enzymes Proteins 0.000 title abstract description 36
- 235000013312 flour Nutrition 0.000 title description 4
- 241000193830 Bacillus <bacterium> Species 0.000 title description 2
- 241001107116 Castanospermum australe Species 0.000 title description 2
- 230000036983 biotransformation Effects 0.000 title description 2
- 235000021279 black bean Nutrition 0.000 title description 2
- 238000011165 process development Methods 0.000 title description 2
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 70
- 244000068988 Glycine max Species 0.000 claims abstract description 67
- 239000000843 powder Substances 0.000 claims abstract description 38
- 241001226430 Bacillus polyfermenticus Species 0.000 claims abstract description 30
- 229940104704 bacillus polyfermenticus Drugs 0.000 claims abstract description 30
- 235000013336 milk Nutrition 0.000 claims abstract description 28
- 239000008267 milk Substances 0.000 claims abstract description 28
- 210000004080 milk Anatomy 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 26
- 238000000855 fermentation Methods 0.000 claims abstract description 23
- 230000004151 fermentation Effects 0.000 claims abstract description 23
- 230000000694 effects Effects 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 20
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 claims description 15
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 claims description 14
- 108091005804 Peptidases Proteins 0.000 claims description 14
- 235000013376 functional food Nutrition 0.000 claims description 10
- 239000004365 Protease Substances 0.000 claims description 9
- 230000036541 health Effects 0.000 claims description 9
- 239000002609 medium Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 108010073682 nattokinase Proteins 0.000 claims description 8
- 229940086319 nattokinase Drugs 0.000 claims description 7
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 abstract description 10
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 6
- 230000000593 degrading effect Effects 0.000 abstract description 4
- 102000056222 Peptide Synthases Human genes 0.000 abstract description 3
- 108700018928 Peptide Synthases Proteins 0.000 abstract description 3
- 229940088598 enzyme Drugs 0.000 description 33
- 239000000243 solution Substances 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 13
- 235000013305 food Nutrition 0.000 description 12
- 102000035195 Peptidases Human genes 0.000 description 11
- 235000013322 soy milk Nutrition 0.000 description 11
- 239000000047 product Substances 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 235000019419 proteases Nutrition 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 108010073771 Soybean Proteins Proteins 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 102000004142 Trypsin Human genes 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000002537 thrombolytic effect Effects 0.000 description 5
- 239000012588 trypsin Substances 0.000 description 5
- 229960001322 trypsin Drugs 0.000 description 5
- 230000009102 absorption Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000005515 coenzyme Substances 0.000 description 4
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 4
- 235000008696 isoflavones Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 4
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
- 229940001941 soy protein Drugs 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- ACIJGUBIMXQCMF-UHFFFAOYSA-N 2-amino-5-(carboxymethylamino)-5-oxopentanoic acid Chemical compound OC(=O)C(N)CCC(=O)NCC(O)=O ACIJGUBIMXQCMF-UHFFFAOYSA-N 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- AQAKHZVPOOGUCK-UHFFFAOYSA-N L-L-gamma-Glutamylvaline Natural products CC(C)C(C(O)=O)NC(=O)CCC(N)C(O)=O AQAKHZVPOOGUCK-UHFFFAOYSA-N 0.000 description 2
- RITKHVBHSGLULN-WHFBIAKZSA-N L-gamma-glutamyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(O)=O RITKHVBHSGLULN-WHFBIAKZSA-N 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- MYFMARDICOWMQP-YUMQZZPRSA-N gamma-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CC[C@H](N)C(O)=O MYFMARDICOWMQP-YUMQZZPRSA-N 0.000 description 2
- AQAKHZVPOOGUCK-XPUUQOCRSA-N gamma-Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CC[C@H](N)C(O)=O AQAKHZVPOOGUCK-XPUUQOCRSA-N 0.000 description 2
- 108010064169 gamma-glutamyl-leucine Proteins 0.000 description 2
- 108010068906 gamma-glutamylcysteine Proteins 0.000 description 2
- 108010032395 gamma-glutamylvaline Proteins 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- -1 potato Natural products 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- MYFMARDICOWMQP-UHFFFAOYSA-N L-L-gamma-Glutamylleucine Natural products CC(C)CC(C(O)=O)NC(=O)CCC(N)C(O)=O MYFMARDICOWMQP-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 102100030569 Nuclear receptor corepressor 2 Human genes 0.000 description 1
- 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 108010041102 azocasein Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 235000019711 black bean protein Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- JBFYFLXEJFQWMU-WDSKDSINSA-N gamma-Glu-Gln Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(O)=O)CCC(N)=O JBFYFLXEJFQWMU-WDSKDSINSA-N 0.000 description 1
- ACIJGUBIMXQCMF-BYPYZUCNSA-N gamma-Glu-Gly Chemical compound OC(=O)[C@@H](N)CCC(=O)NCC(O)=O ACIJGUBIMXQCMF-BYPYZUCNSA-N 0.000 description 1
- 125000002642 gamma-glutamyl group Chemical group 0.000 description 1
- 108010002568 gamma-glutamylglutamine Proteins 0.000 description 1
- 108010006676 gamma-glutamylglycine Proteins 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000019668 heartiness Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000019462 natural additive Nutrition 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000021140 nondigestible carbohydrates Nutrition 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present application relates to a method for preparing bioconversion powders having various improved physiological active functions by treating with an enzyme solution derived from strain Bacillus polyfermenticus, and a method for preparing bioconversion powders using a fermentation broth of strain Bacillus polyfermenticus by confirming that a low molecular weight amino acid, peptide and various functional components are formed by treating whole soybean milk with a fermentation broth mixed with various degrading enzymes and peptide synthetases derived from strain Bacillus polyfermenticus.
Description
Technical Field
The present disclosure relates to a method of preparing black soybean (black soybean) bioconversion powder having enhanced functional and nutritional characteristics, and more particularly, to a method of preparing black soybean bioconversion powder having enhanced various physiological functions by treatment with an enzyme solution derived from Bacillus polyfermenticus strain.
Background
Soybeans contain proteins, fats and various functional components beneficial to the body, and are ideal foods that are nutritionally excellent and important and necessary in the diet. In addition, in recent years, with recently known physiological functions (such as anticancer properties and immune enhancement), the nutritional value of soybean as a functional food is gradually increasing. However, while soybeans play an important role as a nutritional source of protein and fat, dense tissue makes digestion and absorption very difficult. In addition, problems associated with digestion and absorption may occur in case of improper processing due to special odors, nondigestible carbohydrates and physiological inhibitors (e.g., trypsin inhibitors), causing side effects (e.g., diarrhea).
Soy milk is one of the main processed foods of soybean, a representative processed product of soybean having an improved utilization ratio of soybean protein, and is known as a functional nutritional drink because it is rich in soybean protein, essential amino acids and essential fatty acids, and contains a large amount of minerals such as iron, phosphorus and potassium, and physiologically active substances such as isoflavone, saponin and phytic acid as functional components. Recently, studies have been actively conducted to enhance food functionality and develop food-derived functional materials by elucidating the biological regulatory functions of food ingredients.
In the case of soy milk, by treating soy milk with proteolytic enzymes, degrading soy proteins, studies have been conducted to improve functionality by producing peptides having nutritional functions that promote digestion and absorption and physiological activities such as enhancing blood pressure, promoting calcium absorption, anti-allergy, and lowering serum cholesterol. However, there is still insufficient research on the development of functional regulatory biomaterials suitable for enzymatic hydrolysis processing by soy proteins and the industrialization stage of the related materials.
In addition, fermented soybean milk is prepared from soybean as a raw material by subjecting it to fermentation using microorganisms available in foods. And when only soybean is consumed in its original state, only about 30% is absorbed, and the remaining 70% is excreted; while when soybeans are fermented, more than 90% of the nutrients in the soybeans can be absorbed into the body, providing an advantage in nutrient absorption. Among them, fermented soybean milk contains not only the nutrition of soybean but also enzymes produced by microorganisms (such as amylase, protease, lipase and thrombolytic enzyme), and various physiologically active substances produced by the decomposition of these enzymes such as peptides, amino acids, oligosaccharides, fatty acids, active isoflavones, phytosterols, lecithins, saponins and the like. However, soy milk still has problems in terms of: beany flavors (which are special characteristic odors), and unpleasant mouthfeel due to the harsh texture, the soy milk losing its unique flavor due to fermentation and not meeting consumer preference in terms of taste, and the product coagulating or having a strange taste due to heat treatment.
[ Prior Art literature ]
[ patent literature ]
Korean patent application laid-open No. 10-2011-0027247 (published on 16 days of 3 months of 2011).
Disclosure of Invention
Technical object
In order to solve the above problems, an object of the present disclosure is to provide a method of preparing bioconversion powder having enhanced functionality, and a method of preparing bioconversion powder using a fermentation broth of Bacillus polyfermenticus strain by treating whole soybean milk with a fermentation broth in which various degrading enzymes derived from Bacillus polyfermenticus strain and peptide synthase are mixed, thereby determining formation of low molecular weight amino acids, peptides and various functional components.
Technical proposal
The present disclosure provides a method of preparing a bioconversion powder, the method comprising: (1) pulverizing soybeans soaked by immersing in water; (2) Heat-treating the crushed soybeans to obtain whole soybean milk; and (3) treating whole soybean milk with Bacillus polyfermenticus KMU01 (accession number: KCTC 11751 BP) strain, a culture thereof, a fermentation product thereof or a mixture thereof.
Furthermore, the present disclosure provides a health functional food composition comprising a bioconversion powder prepared by the method of preparing the bioconversion powder as an active ingredient.
Advantageous effects
According to the present disclosure, a method for preparing bioconversion powders using the fermentation broth of strain Bacillus polyfermenticus may be provided by treating whole soybean milk with a fermentation broth having mixed therein various degrading enzymes and peptide synthetases derived from strain Bacillus polyfermenticus to determine the formation of low molecular weight amino acids, peptides and various functional components.
Drawings
FIG. 1 shows the genetic map of the Bacillus polyfermenticus KMU01 strain and the genes of the enzyme group.
Fig. 2 shows the results of determining the extent of soy protein degradation and soy peptide production of whole soy milk and bioconversion powders.
FIG. 3 is a graph showing the results of evaluating the antioxidant activity of whole soybean milk and bioconversion powders.
Detailed Description
The terms used herein have been selected as much as possible from general terms currently widely used in view of the functions herein, but these terms may vary according to the intention or precedent of those skilled in the art, the appearance of new technologies, etc. Furthermore, in a specific case, there are terms arbitrarily selected by the applicant, and in this case, the meaning thereof will be described in detail in the specification of the present disclosure. Accordingly, the terms used herein should not be defined as simple names of the terms, but should be based on the meanings of the terms and the entire contents of the present disclosure.
Unless otherwise defined, all terms (including technical or scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Terms (such as those defined in commonly used dictionaries) should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
Numerical ranges include values defined within the ranges. All maximum numerical limits set forth herein include all lower numerical limits as best described for the lower numerical limits. All minimum numerical limits set forth herein include all higher numerical limits as best described for the higher numerical limits. All numerical limits set forth herein will include all better numerical ranges within the broader numerical range as best illustrated for the narrower numerical limits.
Hereinafter, the present disclosure will be described in more detail.
Thus, as a result of an effort to develop a method of preparing bioconversion powders with enhanced functional and nutritional properties, the present inventors have completed the present disclosure by optimizing the enzymatic hydrolysis conditions of whole soybean milk using an enzyme group in which various proteolytic enzymes and peptide synthetases secreted and produced by GRAS-fermented food-derived microorganisms isolated from fermented foods are mixed, and studying the functionality of whole soybean milk hydrolysates to develop bioconversion powders with enhanced functional and nutritional properties and a differential preparation method allowing application in powder form.
Bioconversion refers to a technique of converting an existing material (substrate) by using a microorganism or a biological reaction of an enzyme produced by the microorganism, specifically bioconversion refers to conversion of soybean or black soybean (substrate) using an enzyme group which is a culture supernatant containing therein various enzymes produced by the Bacillus polyfermenticus KMU (accession: KCTC 11751 BP) strain, and a product obtained by the above bioconversion is referred to as bioconversion powder.
The present disclosure provides a method of preparing a bioconversion powder, the method comprising: (1) pulverizing soybeans soaked by immersing in water; (2) Heat-treating the crushed soybeans to obtain whole soybean milk; and (3) treating whole soybean milk with Bacillus polyfermenticus KMU01 (accession number: KCTC 11751 BP) strain, a culture thereof, a fermentation product thereof or a mixture thereof.
Bacillus polyfermenticus KMU01 (accession number: KCTC 11751 BP) strain was registered in Korean type culture Collection (KCTC) under the name of Bacillus amyloliquefaciens (Bacillus amyloliquefaciens) Kimchi at 8.2010, but was renamed to Bacillus polyfermenticus KMU01 at 27.2018 because its exact seed name was identified as Bacillus polyfermenticus.
The soy milk may include all soy milk obtained by a conventional method, and soy milk on the commercial market may be used. For example, a liquid obtained by grinding steamed soybeans that are swelled by immersing peeled soybeans or defatted soybeans in water; and a liquid obtained by removing dregs from the liquid may be used; but is not limited thereto. In addition, a solution in which whole soybean flour or defatted soybean flour is dissolved may be used; according to JAS standards, soybean milk having a soybean solids content of 8.0% or more can be used; the soybean milk with the soybean solid content of more than 6.0% can be used for preparing soybean milk; or soybean milk having a soybean solids content of 4.0% or more may be used as the soybean milk drink, but is not limited in terms of soybean solids content.
Whole soybean milk may be treated with Bacillus polyfermenticus KMU (accession No: KCTC 11751 BP) strain, its culture, its fermentation product, or a mixture thereof at a concentration of 3% (v/v) to 7% (v/v), preferably 5% (v/v).
Bacillus polyfermenticus KMU01 (accession number: KCTC 11751 BP) strain, its culture, its fermentation product or a mixture thereof can be treated at 35℃to 40℃for 3 hours to 5 hours, preferably at 37℃for 4 hours.
The culture may be an artificial medium obtained by culturing the Bacillus polyfermenticus KMU (accession number: KCTC 11751 BP) strain, and the fermentation product may be a natural medium fermented using the Bacillus polyfermenticus KMU (accession number: KCTC 11751 BP) strain.
The artificial medium may be a commercially prepared synthetic medium capable of culturing Bacillus polyfermenticus and bacteria, such as trypsin soybean broth (TBS), trypsin Soybean Broth (TSB), nutrient Broth (NB), and Luria-Bertani broth (LB), but is not limited thereto.
The natural medium refers to a natural product that can be fermented by bacteria, and may be a medium using natural products such as potato, tomato, and milk, but is not limited thereto.
Cultures and fermentation products may exhibit protease, gamma-glutamyl transferase (GGT) and nattokinase activity.
Proteases are enzymes that hydrolyze peptide bonds between amino acids constituting proteins with proteolytic enzymes, some of which include exopeptidases that cleave the amino-terminus (aminopeptidase) or the carboxy-terminus (carboxypeptidase) of the protein, and endopeptidases that cleave the middle of the protein (e.g., trypsin, chymotrypsin, pepsin, papain, elastase). Gamma-glutamyl transferase (GGT) is an enzyme that transfers the glutamyl group in gamma-glutamyl compounds to the appropriate acceptor (amine) and is a transamidase. Nattokinase is a thrombolytic enzyme produced during growth by Bacillus natto (Bacillus natto) upon fermentation of soybeans by ingestion of nutrients of the soybeans, and includes vitamin B complex and a large amount of antioxidant enzyme.
The bioconversion powder may exhibit antioxidant activity.
Furthermore, the present disclosure provides a health functional food composition comprising as an active ingredient a bioconversion powder prepared by the method of preparing the bioconversion powder.
The present disclosure is generally applicable as a general food product.
The food composition of the present disclosure is useful as a health functional food. The term "health functional food" as used herein refers to a food manufactured and processed according to the korean health functional food law with raw materials or ingredients having useful functionalities for the human body, and the term "functional" as used herein refers to the intake of the effectiveness of obtaining health care (e.g., physiological effects of human body structure and function or regulation of nutrients).
The food composition of the present disclosure may contain common food additives, and the applicability as "food additives" is determined by specifications and standards related to respective projects according to general rules and general test methods of the korean food additives code approved by the korean food and drug safety department, unless otherwise specified.
The items listed in the korean food additive code may include, for example: chemically synthesized compounds such as ketones, glycine, potassium citrate, nicotinic acid and cinnamic acid; natural additives such as persimmon pigment, licorice extract, crystalline cellulose, sorghum pigment, and guar gum; and mixed preparations such as sodium L-glutamate preparation, noodle-added alkaline agent, antiseptic and tar colorant.
The food compositions of the present disclosure may be manufactured and processed in the form of tablets, capsules, powders, granules, liquids, and pills.
For example, a hard capsule formulation in a health functional food in the form of a capsule may be prepared by mixing and filling a composition according to the present disclosure with additives (e.g., excipients) in a conventional hard capsule, while a soft capsule formulation may be prepared by mixing a composition according to the present disclosure with additives (e.g., excipients) and then filling it in a capsule matrix (e.g., gelatin). If necessary, the soft capsule formulation may contain a plasticizer (such as glycerin or sorbitol), a colorant, and a preservative.
The definition of terms for excipients, binders, disintegrants, lubricants, flavoring agents and flavoring agents are described in the literature known in the art and include those having the same or similar functions. The type of food is not particularly limited and includes all health functional foods in a general sense.
Examples
Hereinafter, exemplary embodiments will be described in detail to aid in understanding the present disclosure. However, the following exemplary embodiments are merely illustrative of the present disclosure, and the scope of the present disclosure is not limited to the following examples. Exemplary embodiments of the present disclosure are provided to more fully explain the present disclosure to those of ordinary skill in the art.
Example 1 evaluation of various Activity of enzymes derived from fermented food microorganisms
To prepare a functional fermented whole soybean milk, various enzyme activities of the fermentation strain Bacillus polyfermenticus KMU01 (accession: KCTC 11751 BP) strain were evaluated.
First, activities of protease, gamma-glutamyl transferase (GGT) and nattokinase (nattokinase) were evaluated. The fermentation strain was inoculated in 50mL of Trypsin Soybean Broth (TSB) medium and cultured at 37 ℃ for 24 hours, and the culture supernatant was collected and centrifuged at 8000rpm for 20 minutes. The supernatant of the centrifuged culture was used to evaluate the activity of each enzyme.
For protease activity, 0.1mL of 0.5% azocasein solution and 0.1mL coenzyme solution were added as substrates to an Eppendorf tube, and the reaction was carried out at 37℃in a thermostatic water bath for 1 hour, followed by adding 0.4mL of 10% trichloroacetic acid solution to stop the reaction. The reaction solution was centrifuged at 13,000rpm for 5 minutes to collect a supernatant, and then the supernatant was neutralized by adding 0.6mL 0.525N NaOH solution to 0.6mL of the supernatant, absorbance was measured at 420nm, and the amount of enzyme releasing 1 μg tyrosine at 1 minute under the reaction condition was set as 1 unit to evaluate the protease activity.
For gamma-glutamyl transferase (GGT) activity, 0.01mL of coenzyme solution and 0.09mL of 50mM phosphate buffer solution (pH 7.0) containing 0.1mM gamma-L-glutamyl paranitroaniline (p-NA-Glu, sigma-Aldrich) were mixed, reacted at 40℃for 30 minutes, and then 0.01mL of 3.5N acetic acid was added to stop the reaction. The amount of free paranitroaniline was measured at 410 nm. The enzyme activity was calculated by plotting a standard curve using paranitroaniline as a standard solution. For 1 unit of enzyme activity of GGT, the degree of enzyme activity of GGT was evaluated by calculating the amount of enzyme that releases 1 mole of p-nitroaniline from p-NA-Glu per minute.
For nattokinase activity, 350. Mu.L of 50mM boric acid buffer (pH 8.5), 100. Mu.L of 1% fibrinogen solution and 25. Mu.L of 10 unit thrombin solution were mixed, reacted at 37℃for 10 minutes, then 25. Mu.L of coenzyme solution was added, followed by reaction at 37℃for 1 hour. To the reaction solution was added 500. Mu.L of 0.2M TCA solution to stop the reaction, and then the mixture was allowed to stand at 37℃for 10 minutes. After collecting the supernatant by centrifuging the reaction solution at 8,000rpm for 20 minutes, the absorbance of the collected supernatant was measured at 275nm, and the enzyme activity was calculated according to the following calculation formula to evaluate the degree of thrombolytic activity.
Thrombolytic Activity level (FU/mL) =A1-A0/0.01X1/60X 1/0.025 XD
A1: absorbance value of sample
A0: absorbance value (blank) of blank test sample prepared without coenzyme solution
0.01: enzyme activity increased by 0.01 per minute in absorbance
60: enzyme reaction time (min)
0.025: enzyme dosage
D: dilution ratio of sample
As shown in Table 1 below, it was found that the protease activity was 78U/mL, the GGT activity was 3500mU/mL, and the nattokinase activity indicating thrombolytic activity was 24U/mL.
TABLE 1
In addition, the genome of Bacillus polyfermenticus KMU01 (accession number: KCTC 11751 BP) strain was analyzed using a PacBio_20K sequencer and SMRT 2.3.0 (HGAP 2) assembler to identify genes of various functional enzymes. As a result, as shown in FIG. 1, it was confirmed that Bacillus polyfermenticus KMU01 (accession No: KCTC 11751 BP) strain had 61 peptidase genes, 23 protease genes, 8 glucosidase genes, 6 lipase genes, 2 gamma-glutamyl transpeptidase (GGT) genes, 2 cellulase genes, amylase genes and nattokinase genes.
EXAMPLE 2 preparation of functional bioconversion powders Using fermentation strains
The following were used as enzyme solutions for bioconversion of whole soy milk: supernatant obtained by culturing a Bacillus polyfermenticus KMU (accession number: KCTC 11751 BP) strain in Trypsin Soybean Broth (TSB) medium at 37℃for 24 hours. To prepare whole soybean milk, cv.socheongja from Yishan was washed and immersed in water for 14 hours, then water was removed, followed by grinding using a grinder while removing water. The ground sample was boiled at 100 ℃ for 30 minutes, and then whole soybean milk was obtained. The whole soybean milk obtained was treated with an enzyme solution at a ratio of 5% (v/v), subjected to a reaction at 37℃for 4 hours for bioconversion, and subjected to freeze-drying to prepare bioconversion powder.
TABLE 2
Category(s) | Bioconversion conditions |
Whole soybean milk (mL) | 95 |
Enzyme solution (mL) | 5 |
Reaction temperature (. Degree. C.) | 37 |
Reaction time (hr) | 4 |
EXAMPLE 3 evaluation of degree of hydrolysis of bioconversion powders
The degree of hydrolysis of proteins was evaluated on the bioconversion powders prepared in example 2. From each sample, 2mL of the hydrolysate was taken, added to a test tube containing 2mL of 20% (w/v) trichloroacetic acid (TCA), and then centrifuged (3000 Xg, 10 min) after mixing, and a certain amount of the centrifuged supernatant was taken to measure the amount of protein and calculate the degree of hydrolysis. The calculation result revealed that the degree of hydrolysis of the bioconversion powder was 53.8%.
Further, as a result of identifying the molecular weight difference of black bean protein by performing 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), as shown in fig. 2, the content of soybean peptide of 10,000da or less in the bioconversion powder (enzyme-treated black soybean milk) was increased by 1.23 times as compared with the control group (whole black soybean milk).
EXAMPLE 4 compositional analysis of amino acids in bioconversion powders
The bioconversion powders were analyzed for functional amino acids using an automated amino acid analyzer (biochrom30+). As shown in table 3 below, the content of functional amino acids, such as Branched Chain Amino Acids (BCAA) and aromatic amino acids, which are neurotransmitter precursor amino acids, was increased.
TABLE 3 Table 3
EXAMPLE 5 compositional analysis of bioconversion powders
In order to identify the functional components of the bioconversion powder, analyses of soybean dietary fiber, soybean oligosaccharide, isoflavone, flavone and anthocyanin were performed by making requests to korean functional food institute, korean analytical test institute and korean basic science institute. As shown in table 4 below, soy dietary fiber, soy oligosaccharides (raffinose, stachyose), aglycone (aglycon) isoflavones, flavones and anthocyanins were identified as components of bioconversion powders.
TABLE 4 Table 4
Furthermore, as a result of analysis of G-peptide by korean basic science institute, as shown in table 5 below, in enzyme-treated soybean milk, the contents of γ -glutamyl glycine (γ -Glu-Gly), γ -glutamyl-valine (γ -Glu-Val), γ -glutamyl-cysteine (γ -Glu-Cys), γ -glutamyl-leucine (γ -Glu-Leu) and γ -glutamyl-glutamine (γ -Glu-gin) have been increased, and their functions of increasing taste (kokumi) and relieving inflammatory bowel disease and inflammation have been reported.
TABLE 5
EXAMPLE 6 evaluation of antioxidant Activity of bioconversion powders
DPPH radical scavenging activity was analyzed to evaluate the antioxidant activity of bioconversion powders. For DPPH radical scavenging ability, as a method of measuring the degree of DPPH radical reduction using a spectrophotometer by reacting stable free radical 1, 1-diphenyl-2-picrylhydrazyl (DPPH) with a predetermined sample solution, 50 μl of a sample and 50 μl of 0.1mM DPPH solution were mixed, the mixture was allowed to stand in a dark room at room temperature for 30 minutes, and then absorbance was measured at 517nm to calculate the degree of radical reduction compared with the control group. Blank absorbance was measured by mixing 50 μl of water and 50 μl of 0.1mM DPPH solution, and control absorbance of each sample was measured by mixing 50 μl of sample with 95% ethanol. Ascorbic acid was used as a sample for the positive control group. As shown in fig. 3, the bioconversion powder showed 74% high DPPH radical scavenging activity compared to the control group (whole black soy milk).
As described above, a specific portion of the present disclosure is described in detail, and it is apparent to those skilled in the art that the detailed description is merely of a preferred embodiment, and the scope of the present disclosure is not limited thereto. In other words, the true scope of the disclosure may be defined by the following claims and their equivalents.
(translation)
Proof of original preservation
And (3) the following steps: chinese character' Chengwenxi
The glossy privet fruit-tomb hole 861-1 in the north district of the city of korea, university of national, 136-702,
the translated text is not different from the original text |
(translation)
Later demonstration and revision of scientific description and/or taxonomic localization resulted in: chinese character' Chengwenxi
Korea first-hand city, northern area Zhen Ling Lu 77, national university, 02707
Accessories: notification of later specification and revision of scientific description and taxonomic localization according to clause 8.1
The translated text is not different from the original text |
PCT/RO/134 table
Claims (8)
1. A method of preparing a bioconversion powder, the method comprising:
(1) Pulverizing soybeans soaked by immersing in water;
(2) Heat-treating the crushed soybeans to obtain whole soybean milk; and
(3) With accession number: the whole soybean milk is treated with the Bacillus polyfermenticus KMU strain of KCTC 11751BP, a culture thereof, a fermentation product thereof or a mixture thereof.
2. The method of claim 1, wherein the accession number is used at a concentration of 3% (v/v) to 7% (v/v): the Bacillus polyfermenticus KMU strain of KCTC 11751BP, a culture thereof, a fermentation product thereof or a mixture thereof is treated.
3. The method of claim 1, wherein the accession number is used at 35 ℃ to 40 ℃): the Bacillus polyfermenticus KMU strain of KCTC 11751BP, its culture, its fermentation product or its mixture is treated for 3 to 8 hours.
4. The method of claim 1, wherein the culture is obtained by culturing the accession number: an artificial medium obtained from strain Bacillus polyfermenticus KMU01 of KCTC 11751 BP.
5. The method of claim 1, wherein the fermentation product is produced using the accession number: a native culture medium fermented by the Bacillus polyfermenticus KMU strain Bacillus polyfermenticus KMU of KCTC 11751 BP.
6. The method of claim 1, wherein the culture and the fermentation product exhibit protease, gamma-glutamyl transferase (GGT) and nattokinase activity.
7. The method of claim 1, wherein the bioconversion powder exhibits antioxidant activity.
8. A health functional food composition comprising as an active ingredient the bioconversion powder prepared by the method of any one of claims 1-7.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2020-0121670 | 2020-09-21 | ||
KR10-2021-0124802 | 2021-09-17 | ||
KR1020210124802A KR20220039618A (en) | 2020-09-21 | 2021-09-17 | Development of bioconversion process of bioconverted functional soybean powder using enzymes from Bacillus and its use |
PCT/KR2021/012930 WO2022060200A2 (en) | 2020-09-21 | 2021-09-23 | Development of bioconversion process for functional black soybean powder bioconverted using enzyme group derived from bacillus bacteria and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116634890A true CN116634890A (en) | 2023-08-22 |
Family
ID=87642196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202180077992.6A Withdrawn CN116634890A (en) | 2020-09-21 | 2021-09-23 | Bioconversion process development and application of functional black bean flour by biotransformation of enzyme group derived from bacillus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116634890A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112639075A (en) * | 2018-06-26 | 2021-04-09 | 国民生物公司 | Novel halophilic multiple fermentation bacillus strain producing salt tolerant gamma-glutamyl transpeptidase |
-
2021
- 2021-09-23 CN CN202180077992.6A patent/CN116634890A/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112639075A (en) * | 2018-06-26 | 2021-04-09 | 国民生物公司 | Novel halophilic multiple fermentation bacillus strain producing salt tolerant gamma-glutamyl transpeptidase |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Whole soybean as probiotic lactic acid bacteria carrier food in solid-state fermentation | |
US9894920B2 (en) | Yeast fermentation of rice bran extracts | |
CN101708043B (en) | Active natto hot and spicy sauce and processing method thereof | |
RU2693610C1 (en) | Method for preparation of rice paste with hot pepper and rice paste prepared in such way with hot pepper | |
JPH025830A (en) | Enzymatic hydrolysis of protein | |
Wang et al. | Functionalization of soy residue (okara) by enzymatic hydrolysis and LAB fermentation for B2 bio-enrichment and improved in vitro digestion | |
CN116634890A (en) | Bioconversion process development and application of functional black bean flour by biotransformation of enzyme group derived from bacillus | |
CN111493292A (en) | A method for preparing refined paste from marine organism and/or marine product processing waste | |
KR100788764B1 (en) | Ferment-composite using soybean-fluid and Functional foods | |
US20230381259A1 (en) | Development of bioconversion process for functional black soybean powder bioconverted using enzyme group derived from bacillus bacteria and use thereof | |
KR20220039618A (en) | Development of bioconversion process of bioconverted functional soybean powder using enzymes from Bacillus and its use | |
CN111991280A (en) | Anti-allergy bean fermentation extract, product and preparation method thereof | |
KR20090117363A (en) | Mixed culturing method of aspergillus oryzae and bacillus subtilis in rice bran, and it's processing methods | |
KR100485267B1 (en) | Fermented soymilk having totally hydrolyzed isoflavones and method for preparation of same | |
KR20170081634A (en) | Manufacturing method of cheonggukjang using the Bacillus subtilis strain SCM 685 having antimicrobial activity against pathogenic microorganism of soy sauce and degrading activity of biogenic amine | |
KR100927573B1 (en) | A method of preparing seed cell for natto using Bacillus subtilis BN-NUC1(KCCM-10839P) | |
Yin et al. | Proteolysis and Lactobacillus fermentation effects on the isoflavones biotransformation and removal of anti-nutritional factors of soy bean | |
KR101866468B1 (en) | Enzyme food and diet enzyme food comprising concentrated product by fermentation of grains, and their preparation method | |
TWI425087B (en) | Process for producing bacillus subtilis natto and/or nattokinase and fermented product obtained thereform | |
Titilayo et al. | Biochemical changes and sensory evaluation of soy iru produced using starter culture | |
JP4794486B2 (en) | Fermented food combined with medium and method for producing the same | |
KR20160097743A (en) | Manufacturing method of cheonggukjang using the Bacillus subtilis strain SCM 685 having antimicrobial activity against pathogenic microorganism of soy sauce and degrading activity of biogenic amine and cheonggukjang manufactured by thereof | |
Pahadi | EXTRACTION, PARTIAL PURIFICATION AND CHARACTERIZATION OF KINEMA PROTEASE PRODUCED FROM WHITE SOYABEAN | |
Azokpota | Quality aspects of alkaline-fermented foods | |
KR20180046087A (en) | Fermented soybean paste containing Condonopsis lanceolata, ballonflower and manufacturing method there of |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230822 |
|
WW01 | Invention patent application withdrawn after publication |